HSP90B2P and cancer: Different studies reported different variants of HSP-based vaccines designed to target SRs, which included the harvesting of autologous HSP-TAA complexes [159], in vitro constructed HSP-TSA complexes [160,161] and fusions of HSPs to cancer peptides [162].